0001093557-16-000697.txt : 20160913
0001093557-16-000697.hdr.sgml : 20160913
20160913203330
ACCESSION NUMBER: 0001093557-16-000697
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160909
FILED AS OF DATE: 20160913
DATE AS OF CHANGE: 20160913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOUBLEDAY RICHARD
CENTRAL INDEX KEY: 0001466545
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 161883999
MAIL ADDRESS:
STREET 1: C/O DEXCOM, INC.
STREET 2: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-09-09
0
0001093557
DEXCOM INC
DXCM
0001466545
DOUBLEDAY RICHARD
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
EVP, Chief Commercial Officer
Common Stock
2016-09-09
4
D
0
4445.0
93.7227
D
87805
D
Common Stock
2016-09-09
4
D
0
4223.0
93.7227
D
83582
D
Common Stock
31825
I
by Trust
These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
Included in this number are 70,084 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 23,750 of which were granted on March 8, 2015 and shall vest through March 8, 2018, and 8,334 of which were granted on March 8, 2014 and shall vest through March 8, 2017.
Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.
CONFIRMING STATEMENT: This Statement confirms that the undersigned Richard Doubleday, has authorized and designated Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of DexCom, Inc. The authority of Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of DexCom, Inc., unless earlier revoked in writing. The undersigned acknowledges that Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. Date: August 31, 2016 /s/ RICHARD DOUBLEDAY Richard Doubleday
By: Kevin Sun For: Richard B. Doubleday
2016-09-13